Inhibrx Biosciences (INBX) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to -$213.4 million.
- Inhibrx Biosciences' Retained Earnings fell 26603.77% to -$213.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.4 million, marking a year-over-year decrease of 26603.77%. This contributed to the annual value of -$106.1 million for FY2024, which is 8270.72% up from last year.
- Inhibrx Biosciences' Retained Earnings amounted to -$213.4 million in Q3 2025, which was down 26603.77% from -$178.1 million recorded in Q2 2025.
- Inhibrx Biosciences' Retained Earnings' 5-year high stood at -$14.4 million during Q2 2024, with a 5-year trough of -$613.7 million in Q4 2023.
- In the last 3 years, Inhibrx Biosciences' Retained Earnings had a median value of -$149.4 million in 2025 and averaged -$190.5 million.
- Per our database at Business Quant, Inhibrx Biosciences' Retained Earnings soared by 8270.72% in 2024 and then tumbled by 113654.79% in 2025.
- Inhibrx Biosciences' Retained Earnings (Quarter) stood at -$613.7 million in 2023, then skyrocketed by 82.71% to -$106.1 million in 2024, then crashed by 101.07% to -$213.4 million in 2025.
- Its Retained Earnings stands at -$213.4 million for Q3 2025, versus -$178.1 million for Q2 2025 and -$149.4 million for Q1 2025.